$0.31
-0.02 (-5.86%)
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+945.2% upside
Low Target
$1.82
Average Target
$3.24
High Target
$4.40
Current Price
$0.31
Current
$0.31
$0.31
Target
$3.24
$3.24
$1.82
$3.24 avg
$4.40
Scenario Analysis
Bear Case
$1.82
487.1%
Low target
Base Case
$3.24
+945.2%
Avg target
Bull Case
$4.40
+1,319.4%
High target
Risk/Reward
2.7x
Favorable
Price in Context
52-Week High
$2.88
-89.2% from high
52-Week Low
$0.29
+6.9% from low
Target vs 52W High
$3.24
+12.5% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -3.3% |
| AMGN | Hold | 43 | 47% | $190.87 | -54.4% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +138.3% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -16.9% |
| REGN | Buy | 38 | 68% | $76.80 | -89.8% |
| MRNA | Hold | 30 | 37% | $149.45 | -24.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -65.3% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -43.4% |